Doxorubicin‐Induced Cardiomyopathy in Children

Mancilla, Trevi R., Iskra, Brian, Aune, Gregory J.·2019·Comprehensive Physiology
DOI 10.1002/cphy.c180017

Cites (361)

Items 201–362 of 362

  1. ErbB2 overexpression upregulates antioxidant enzymes, reduces basal levels of reactive oxygen species, and protects against doxorubicin cardiotoxicity
    Frances R. Belmonte, Samarjit Das, Polina Sysa‐Shah, Vidhya Sivakumaran, Brian A. Stanley, Xin Guo, Nazareno Paolocci, Miguel Antonio Aon, Masaki Nagane, Periannan Kuppusamy et al. · 2015 · American Journal of Physiology-Heart and Circulatory Physiology
  2. Gp91phox-containing NAD(P)H oxidase increases superoxide formation by doxorubicin and NADPH
    Shiwei Deng, Anke Kruger, Andrei L. Kleschyov, Leszek Kalinowski, Andreas Daiber, Leszek Wojnowski · 2006 · Free Radical Biology and Medicine
  3. Power output is linearly related to MyHC content in rat skinned myocytes and isolated working hearts
    F. Steven Korte, Todd J. Herron, Michael J. Rovetto, Kerry S. McDonald · 2005 · American Journal of Physiology-Heart and Circulatory Physiology
  4. The protective roles of nitric oxide and superoxide dismutase in adriamycin-induced cardiotoxicity
    Marsha Paulette Cole, Luksana Chaiswing, Terry D. Oberley, Stephanie E. Edelmann, M T Piascik, S LIN, Kelley K. Kiningham, Daret K. St. Clair · 2005 · Cardiovascular Research
  5. Protective Effect of Carvedilol on Adriamycin-Induced Left Ventricular Dysfunction in Children With Acute Lymphoblastic Leukemia
    Nagla A. El‐Shitany, Osama Tolba, Mohamed Ramadan El-Shanshory, Eslam Elsayed Elhawary · 2012 · Journal of Cardiac Failure
  6. Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French Adjuvant Study Group Results
    P. Fumoleau, Henri Hubert Roche, Pierre Kerbrat, Jacques M Bonneterre, Pascale Romestaing, Pierre Fargeot, Mo�se Namer, Alain Monnier, Philippe Montcuquet, Marie-Josèphe Goudier et al. · 2005 · Annals of Oncology
  7. Brain Natriuretic Peptide Is a Predictor of Anthracycline-Induced Cardiotoxicity
    Hirokazu Okumura, Kazuyuki Iuchi, Takashi Yoshida, Shinobu Nakamura, Minoru Takeshima, Hideyuki Takamatsu, Atsuhisa Ikeno, Kazuo Usuda, Tadao Ishikawa, Shigeki Ohtake et al. · 2000 · Acta Haematologica
  8. Reduction of chronic doxorubicin cardiotoxicity in dogs by pretreatment with (+/-)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187).
    Eugene H. Herman, Victor J. Ferrans · 1981 · PubMed
  9. Pathology of late-onset anthracycline cardiomyopathy
    Bob N Bernaba, Jessica B. Chan, Chi K. Lai, Michael C. Fishbein · 2009 · Cardiovascular Pathology
  10. The use of serum levels of cardiac troponin T to compare the protective activity of dexrazoxane against doxorubicin- and mitoxantrone-induced cardiotoxicity
    Eugene H. Herman, Jun Zhang, Nader Rifai, Steven E. Lipshultz, Brian B. Hasinoff, Douglas P. Chadwick, Alan D. Knapton, Jonathan Chai, Victor J. Ferrans · 2001 · Cancer Chemotherapy and Pharmacology
  11. Assessment of Myocardial Viability at Dobutamine Echocardiography by Deformation Analysis Using Tissue Velocity and Speckle-Tracking
    Manish Bansal, Leanne Jeffriess, Rodel Leano, Julie A. Mundy, Thomas Hugh Marwick · 2010 · JACC. Cardiovascular imaging
  12. Effects of adriamycin on respiratory chain activities in mitochondria from rat liver, rat heart and bovine heart. Evidence for a preferential inhibition of complex III and IV
    Klaas Nicolay, Ben DE KRUIJFF · 1987 · Biochimica et Biophysica Acta (BBA) - Bioenergetics
  13. Blood Pressure Status in Adult Survivors of Childhood Cancer: A Report from the St. Jude Lifetime Cohort Study
    Todd M. Gibson, Zhenghong Li, Daniel M. Green, Gregory T. Armstrong, Daniel A. Mulrooney, Deo Kumar Srivastava, Nickhill Hitesh Bhakta, Kirsten K. Ness, Melissa Maria Hudson, Leslie L. Robison · 2017 · Cancer Epidemiology Biomarkers & Prevention
  14. Protective effects of carvedilol against doxorubicin-induced cardiomyopathy in rats
    Hideo Matsui, Itsuro Morishima, Yasushi Numaguchi, Yukio Toki, Kenji Okumura, Tetsuo Hayakawa · 1999 · Life Sciences
  15. A Deletion of Mitochondrial DNA in Murine Doxorubicin-Induced Cardiotoxicity
    K. Adachi, Yoshihisa Fujiura, Fumihito Mayumi, Akira Nozuhara, Yuji Sugiu, Toshihiko Sakanashi, T. Hidaka, Hironori Toshima · 1993 · Biochemical and Biophysical Research Communications
  16. Dietary vitamin E decreases doxorubicin-induced oxidative stress without preventing mitochondrial dysfunction
    Berthiaume, J. M., Oliveira, P. J., Fariss, M. W., Wallace, K. B. · 2005 · Cardiovascular Toxicology
  17. Shear Stress Enhances Glutathione Peroxidase Expression in Endothelial Cells
    Saori Takeshita, Nobutaka Inoue, Tomomi Ueyama, Seinosuke Kawashima, Mitsuhiro Yokoyama · 2000 · Biochemical and Biophysical Research Communications
  18. Dose escalation and pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in children with solid tumors: a pediatric oncology group study.
    Neyssa M. Marina, Debon Cochrane, Elaine Harney, Katie Zomorodi, Susan M. Blaney, Naomi Joan Winick, Mark L. Bernstein, Michael Paul Link · 2002 · PubMed
  19. Non-invasive imaging and monitoring cardiotoxicity of cancer therapeutic drugs
    Ronny S. Jiji, Christopher M. Kramer, Michael Salerno · 2012 · Journal of Nuclear Cardiology
  20. Attenuation of doxorubicin-induced contractile and mitochondrial dysfunction in mouse heart by cellular glutathione peroxidase
    Ye Xiong, Xuwan Liu, Chuan-Pu Lee, Balvin H.L. Chua, Ye-Shih Ho · 2006 · Free Radical Biology and Medicine
  21. Increased Plasma Endothelin-1 and Cardiac Nitric Oxide during Doxorubicin-Induced Cardiomyopathy
    Mohamed M. Sayed‐Ahmed, Mahmoud Mohamed Khattab, Mohamed Zakaria Gad, Abdel‐Moneim M. Osman · 2001 · Pharmacology & Toxicology
  22. Evaluation of the topoisomerase II-inactive bisdioxopiperazine ICRF-161 as a protectant against doxorubicin-induced cardiomyopathy
    Elke Martin, Annemette Thougaard, Morten Grauslund, Peter Buhl Jensen, Fredrik Björkling, Brian B. Hasinoff, Jette Tjørnelund, Maxwell Sehested, Lars H. Jensen · 2008 · Toxicology
  23. Cirrhosis and hepatoma occurring at Boston city hospital (1917-1968)
    David T. Purtilo, Leonard S. Gottlieb · 1973 · Cancer
  24. Tissue inhibitor of metalloproteinases‐3 and matrix metalloproteinase‐3 regulate neuronal sensitivity to doxorubicin‐induced apoptosis
    Monica K. Wetzel, Gary A. Rosenberg, Lee Anna Cunningham · 2003 · European Journal of Neuroscience
  25. Mechanism of inhibition of mitochondrial enzymatic complex I–III by adriamycin derivatives
    Erik Goormaghtigh, Pascal Huart, Robert Brasseur, Jean‐Marie Ruysschaert · 1986 · Biochimica et Biophysica Acta (BBA) - Biomembranes
  26. An Engineered Bivalent Neuregulin Protects Against Doxorubicin-Induced Cardiotoxicity With Reduced Proneoplastic Potential
    Steven M. Jay, Ashwin C. Murthy, Jessica F. Hawkins, Joshua R. Wortzel, Matthew L. Steinhauser, Luis M. Alvarez, Joseph Gannon, Calum A. MacRae, Linda Gay Griffith, Richard Theodore Lee · 2013 · Circulation
  27. Induction chemotherapy for breast carcinoma: predictive markers and relation with outcome
    Frederique Madeleine Penault-Llorca, Anne Cayre, Florence Mishellany, Sophie Amat, V. Feillel, Guillaume Le Bouëdec, Jean-Pierre Ferrière, Monique de Latour, Philippe J. M. Chollet · 2003 · International Journal of Oncology
  28. Over-Expression of Heat Shock Protein 27 Attenuates Doxorubicin-Induced Cardiac Dysfunction in Mice
    Li Liu, Xiaojin Zhang, Bo Qian, Xiaoyan Min, Xiang Gao, Chuanfu Li, Yunlin Cheng, Jun Huang · 2007 · European Journal of Heart Failure
  29. Identification of novel biomarkers for doxorubicin-induced toxicity in human cardiomyocytes derived from pluripotent stem cells
    Gustav Holmgren, Jane Synnergren, Yalda Rahpeymai Bogestål, Caroline Améen, Karolina Åkesson, Sandra Holmgren, Anders H. Lindahl, Peter Sartipy · 2014 · Toxicology
  30. Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol
    A J Nichols, M. Gellai, R. Ruffolo · 1991 · Fundamental and Clinical Pharmacology
  31. Reversible tenfod reduction in mitochondrial DNA content of human cells treated with ethidium bromide
    Andrew Wiseman, Giuseppe M. Attardi · 1978 · Molecular and General Genetics MGG
  32. Rapid-onset endothelial dysfunction with adriamycin: evidence for a dysfunctional nitric oxide synthase
    Damon C. Duquaine, Glenn A. Hirsch, Anjan K. Chakrabarti, Zhenguo Han, Christine Kehrer, Robert D. Brook, Joy Joseph, Anne F. Schott, Balaraman Kalyanaraman, Jeanette Vasquez-Vivar et al. · 2003 · Vascular Medicine
  33. Annexin V imaging of acute doxorubicin cardiotoxicity (apoptosis) in rats.
    Roel J. Bennink, Maurice J.B. van den Hoff, Formijn J. van Hemert, Kora M. de Bruin, Astrid L. Spijkerboer, Jean‐Luc Vanderheyden, Neil D. Steinmetz, Berthe L.F. van Eck‐Smit · 2004 · PubMed
  34. Mitochondrial dynamics: orchestrating the journey to advanced age
    Biala, Agnieszka K., Dhingra, Rimpy, Kirshenbaum, Lorrie A. · 2015 · Journal of Molecular and Cellular Cardiology
  35. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer
    Elvira C van Dalen, Martine F. Raphaël, Huib N. Caron, Leontien C.M. Kremer · 2014 · Cochrane Database of Systematic Reviews
  36. p38 MAPK and JNK Antagonistically Control Senescence and Cytoplasmic p16INK4A Expression in Doxorubicin-Treated Endothelial Progenitor Cells
    Paolo Spallarossa, Paola Altieri, Chiara Barisione, Mario Passalacqua, Concetta Aloi, Giuseppina Fugazza, Francesco Frassoni, Marina Podestà, Marco Canepa, G Ghigliotti et al. · 2010 · PLoS ONE
  37. Heat Shock Protein 90 and ErbB2 in the Cardiac Response to Doxorubicin Injury
    Kathleen L. Gabrielson, Djahida Bedja, Scott Pin, Allison L. Tsao, Lúcio Gama, Bibo Yuan, Nicole Muratore · 2007 · Cancer Research
  38. Exercise-Induced Modulation of Endothelial Nitric Oxide Production
    Stephan Gielen, Marcus Sandri, Sandra Erbs, Volker Adams · 2011 · Current Pharmaceutical Biotechnology
  39. Genetic and clinical factors associated with obesity among adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort
    Carmen Louise Wilson, Wei Liu, Jun J.J. Yang, Guolian Kang, Rohit P. Ojha, Geoffrey A. M. Neale, Deo Kumar Srivastava, James G. Gurney, Melissa Maria Hudson, Leslie L. Robison et al. · 2015 · Cancer
  40. Cause of mortality in 5‐year survivors of childhood cancer
    Ann C. Mertens · 2007 · Pediatric Blood & Cancer
  41. Effects of Shear Stress on the Gene Expressions of Endothelial Nitric Oxide Synthase, Endothelin-1, and Thrombomodulin in Human Retinal Microvascular Endothelial Cells
    Akihiro Ishibazawa, Taiji Nagaoka, Tatsuhisa Takahashi, Kimiko Yamamoto, Akira Kamiya, Joji Ando, Akitoshi Yoshida · 2011 · Investigative Ophthalmology & Visual Science
  42. Anthracycline‐Induced Cardiomyopathy in Adults
    Timothy C. Tan, Tomas G. Neilan, Sanjeev A Francis, Juan Carlos Plana, Marielle Scherrer‐Crosbie · 2015 · Comprehensive physiology
  43. Tissue Doppler imaging in detection of myocardial dysfunction in survivors of childhood cancer treated with anthracyclines
    Livia Kapusta, JOHAN M. THIJSSEN, Jacqueline J. Loonen, Timothy A. J. Antonius, Jan Mulder, Otto Daniëls · 2000 · Ultrasound in Medicine & Biology
  44. Increased therapeutic index of weekly doxorubicin in the therapy of non-small cell lung cancer: a prospective, randomized study.
    Manuel Valdivieso, Michael A. Burgess, Michael S. Ewer, B Mackay, S Wallace, Robert S. Benjamin, M.K.K. Ali, Gerald P. Bodey, Emil J. Freireich · 1984 · Journal of Clinical Oncology
  45. Matrix metalloproteinase activation is an early event in doxorubicin-induced cardiotoxicity
    Péter Bai, Jon G. Mabley, Lucas Liaudet, László Virág, Csaba Szabó, Pál Pacher · 2004 · Oncology Reports
  46. Adriamycin and Radiation: Synergistic Cardiotoxicity
    JOHN MERRILL, F. ANTHONY GRECO, HARVEY ZIMBLER, HARMAR D. BRERETON, JOHN D. LAMBERG, THOMAS C. POMEROY · 1975 · Annals of Internal Medicine
  47. Can cellular transplantation improve function in doxorubicin-induced heart failure?
    Marcio Scorsin, Albert Alain Hagège, I. Dolizy, F. Marotte, Nicolas Mirochnik, Henri Copin, M. Barnoux, Marc Le Bert, Jane‐Lise Samuel, L. Rappaport et al. · 1998 · PubMed
  48. Doxorubicin and paclitaxel, a highly active combination in the treatment of metastatic breast cancer.
    P Dombernowsky, Julie Gehl, Michael W. Boesgaard, T Paaske, Benny Vittrup Jensen · 1996 · PubMed
  49. Doxorubicin-induced cardiotoxicity: direct correlation of cardiac fibroblast and H9c2 cell survival and aconitase activity with heat shock protein 27
    Samir Turakhia, C. D. Venkatakrishnan, Kathy Dunsmore, Hector R. Wong, Periannan Kuppusamy, Jay Louis Zweier, Govindasamy Ilangovan · 2007 · American Journal of Physiology-Heart and Circulatory Physiology
  50. Solution chemistry studies of adriamycin-iron complexes present in vivo
    Peter M. May, Gillian K. Williams, David R. Williams · 1980 · European Journal of Cancer (1965)
  51. Temporal patterns of bone marrow cell differentiation following transplantation in doxorubicin-induced cardiomyopathy
    Agbulut, O · 2003 · Cardiovascular Research
  52. ACUTE LYMPHOBLASTIC LEUKÆMIA TREATED WITH A COMBINATION OF PREDNISONE, VINCRISTINE, AND RUBIDOMYCIN
    G Mathé, M. Hayat, L Schwarzenberg, J.L. Amiel, Maurice Schneider, A. R. Cattan, Jean Schlumberger, C Jasmin · 1967 · The Lancet
  53. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer
    Daniel KL Cheuk, Elske Sieswerda, Elvira C van Dalen, Aleida Postma, Leontien C.M. Kremer · 2016 · Cochrane Database of Systematic Reviews
  54. Temporal Trends in Treatment and Outcomes for Advanced Heart Failure With Reduced Ejection Fraction From 1993–2010
    John C. Loh, Julie W. Creaser, Darlene Rourke, Nancy Livingston, Tamara K. Harrison, Elizabeth Vandenbogaart, Jaime D. Moriguchi, Michèle A. Hamilton, Chi‐Hong Tseng, Gregg C. Fonarow et al. · 2013 · Circulation Heart Failure
  55. Baseline diastolic dysfunction as a predictive factor of trastuzumab-mediated cardiotoxicity after adjuvant anthracycline therapy in breast cancer
    Alexandre Cochet, Gaëtan Quilichini, Inna Dygai‐Cochet, Claude Touzery, Michel Toubeau, Alina Berriolo-Riedinger, Bruno P. Coudert, Yves Cottin, P. Fumoleau, François Brunotte · 2011 · Breast Cancer Research and Treatment
  56. Demonstration of the existence of an organo‐specific NADH dehydrogenase in heart mitochondria
    Hans Nohl · 1987 · European Journal of Biochemistry
  57. Cardiovascular sequelae in long-term survivors of young peoples’ cancer: a linked cohort study
    Marlous Van Laar, Richard G. Feltbower, Chris P Gale, David Bowen, S E Oliver, Adam Glaser · 2014 · British Journal of Cancer
  58. Chronic cardiotoxicity of doxorubicin involves activation of myocardial and circulating matrix metalloproteinases in rats
    Monika Ivanová, Ima Dovinová, Ľudmila Okruhlicová, Narcisa Tribulová, Petra Šimončíková, Monika Barteková, Jana Vlkovičová, Miroslav Barančı́k · 2012 · Acta Pharmacologica Sinica
  59. New biomarkers for early detection of cardiotoxicity after treatment with docetaxel, doxorubicin and cyclophosphamide
    Wim van Boxtel, Ben F. Bulten, Annelies M. C. Mavinkurve‐Groothuis, Louise Bellersen, C. M. P. W. Mandigers, Leo A. B. Joosten, Livia Kapusta, Lioe‐Fee de Geus‐Oei, Hanneke W.M. van Laarhoven · 2015 · Biomarkers
  60. Anatomic distribution of nitric oxide synthase in the heart
    Philip C. Ursell, Margaret Mayes · 1995 · International Journal of Cardiology
  61. ADAM19/Adamalysin 19 Structure, Function, and Role as a Putative Target in Tumors and Inflammatory Diseases
    Bin Qi, Robert Newcomer, Qing‐Xiang Amy Sang · 2009 · Current Pharmaceutical Design
  62. Myocardial Strain and Strain Rate in Monitoring Subclinical Heart Failure in Asymptomatic Long-Term Survivors of Childhood Cancer
    Annelies M. C. Mavinkurve‐Groothuis, Jacqueline J. Loonen, Karen A. Marcus, Louise Bellersen, Ton B. Feuth, Jos P.M. Bökkerink, Peter M. Hoogerbrugge, Chris L. de Korte, Livia Kapusta · 2010 · Ultrasound in Medicine & Biology
  63. Repetitive Dobutamine Stress Echocardiography for the Prediction of Anthracycline Cardiotoxicity
    Manolis Bountioukos · 2003 · European Journal of Echocardiography
  64. Liposomes as drug carriers in cancer therapy.
    John N. Weinstein · 1984 · PubMed
  65. Endothelin in chronic heart failure: current position and future prospects
    Michael P. Love, John J.V. McMurray · 1996 · Cardiovascular Research
  66. Therapy Insight: anthracyclines and trastuzumab—the optimal management of cardiotoxic side effects
    Sanjay Popat, Ian E. Smith · 2008 · Nature Clinical Practice Oncology
  67. Role of renal function on the development of cardiotoxicity associated with trastuzumab-based adjuvant chemotherapy for early breast cancer
    Giulia Russo, Giovanni Cioffi, Andrea Di Lenarda, Fausto Tuccia, Daniella Bovelli, Giuseppe Di Tano, Gianfranco Alunni, Stefania Gori, Pompilio Massimo Faggiano, Luigi Tarantini · 2012 · Internal and Emergency Medicine
  68. A chemical perspective on the anthracycline antitumor antibiotics.
    Beth R. J. Abdella, Jed F. Fisher · 1985 · Environmental Health Perspectives
  69. Permanent cell cycle arrest in asynchronously proliferating normal human fibroblasts treated with doxorubicin or etoposide but not camptothecin
    Steven J. Robles, Paul W. Buehler, Adam Negrusz, Guy R. Adami · 1999 · Biochemical Pharmacology
  70. Effects of Angiotensin-Converting Enzyme Inhibitor on Delayed-Onset Doxorubicin-Induced Cardiotoxicity
    Robert J. Boucek, Ann Steele, Ann L. Miracle, James Atkinson · 2003 · Cardiovascular Toxicology
  71. Novel Toll-like receptor-4 deficiency attenuates trastuzumab (Herceptin) induced cardiac injury in mice
    Nasser Ghaly Yousif, Fadhil G. Al-Amran · 2011 · BMC Cardiovascular Disorders
  72. Deferiprone Does Not Protect against Chronic Anthracycline Cardiotoxicity in Vivo
    Olga Popelová, Martin Štěrba, Tomáš Šimůnek, Y Mazurová, Ivana Němečková, Milos Hroch, Michaela Adamcová, Vladimír Geršl · 2008 · Journal of Pharmacology and Experimental Therapeutics
  73. Sex-related Differences in Mast Cell Activity and Doxorubicin Toxicity
    Jun Zhang, Alan D. Knapton, Steven E. Lipshultz, Thomas R. Cochran, Hajime Hiraragi, Eugene H. Herman · 2013 · Toxicologic Pathology
  74. Prospective evaluation of cardiotoxicity during a six-hour doxorubicin infusion regimen in women with adenocarcinoma of the breast
    James L. Speyer, M.D. Green, Neil Dubin, Ronald H. Blum, J Wernz, Daniel F. Roses, Joseph J. Sanger, Franco M. Muggia · 1985 · The American Journal of Medicine
  75. Aerobic Exercise During Early Murine Doxorubicin Exposure Mitigates Cardiac Toxicity
    Fei Wang, Brian S. Iskra, Eugenie S. Kleinerman, Claudia Alvarez‐Florez, Thomas C. Andrews, Angela Shaw, Joya Chandra, Keri Schadler, Gregory John Aune · 2018 · Journal of Pediatric Hematology/Oncology
  76. Mitochondrial DNA and its respiratory chain products are defective in doxorubicin nephrosis
    Dirk Lebrecht · 2004 · Nephrology Dialysis Transplantation
  77. Impairment of diastolic function during short-term anthracycline chemotherapy.
    Yves Cottin, Claude Touzery, Bruno P. Coudert, Axelle Gilles, Paul M. Walker, J L Massing, Michel Toubeau, Alina Berriolo-Riedinger, Denis Caillot, Pierre Louis · 1995 · Heart
  78. Enhanced gene expression of myocardial matrix metalloproteinases 2 and 9 after acute treatment with doxorubicin in mice
    Keiichiro Kizaki, Ryôichi Itô, Muneyoshi Okada, Kazuki Yoshioka, Tsuyoshi Uchide, Kyosuke Temma, Ken-ichiro MUTOH, Masami Uechi, Yukio Hara · 2006 · Pharmacological Research
  79. Distribution and antitumor activity of adriamycin given in a high-dose and a repeated low-dose schedule to mice.
    Maria Adele Pacciarini, Brunella Barbieri, Tina Colombo, Massimo Broggini, Silvio K. Garattini, Maria Grazia Donelli · 1978 · PubMed
  80. Acute Doxorubicin Cardiotoxicity
    Peter C. D. Pelikan, Myron L. Weisfeldt, William E. Jacobus, Michael V. Miceli, Bernadine Healy Bulkley, Gary Gerstenblith · 1986 · Journal of Cardiovascular Pharmacology
  81. Rubidomycin in Acute Leukaemia in Adults
    J. S. Malpas, Ronald Bodley Scott · 1968 · BMJ
  82. Alterations of Intracellular Calcium Homeostasis and Myocardial Energetics in Acute Adriamycin-Induced Heart Failure
    Hideo Kusuoka, Shiho Futaki, Yukihiro Koretsune, Akira Kitabatake, Hiroyuki Suga, Takenobu Kamada, Michitoshi Inoue · 1991 · Journal of Cardiovascular Pharmacology
  83. Impaired dynamics and function of mitochondria caused by mtDNA toxicity leads to heart failure
    Knut Husø Lauritzen, Liv Kleppa, Jan Magnus Aronsen, Lars Eide, Harald Carlsen, Øyvind P. Haugen, Ivar Sjaastad, Arne Klungland, Lene Juel Rasmussen, Håvard Attramadal et al. · 2015 · American Journal of Physiology-Heart and Circulatory Physiology
  84. Myocarditis Associated with Doxorubicin Cardiotoxicity
    Paul B. Gaudin, Ralph H. Hruban, William E. Beschorner, Edward K. Kasper, Jean L. Olson, Kenneth Lee Baughman, Grover M. Hutchins · 1993 · American Journal of Clinical Pathology
  85. Doxorubicin Increases Oxidative Metabolism in HL-1 Cardiomyocytes as Shown by 13C Metabolic Flux Analysis
    Alexander Strigun, Judith Wahrheit, Jens Niklas, Elmar Heinzle, Fozia Noor · 2011 · Toxicological Sciences
  86. A molecular MRI probe to detect treatment of cardiac apoptosis in vivo
    Rajesh Dash, Jaehoon Chung, Trevor Chan, Mayumi Yamada, Joelle K. Barral, Dwight G. Nishimura, Phillip Chung-Ming Yang, Paul C. Simpson · 2011 · Magnetic Resonance in Medicine
  87. Activity of d,l‐α‐Tocopherol (Vitamin E) against Cardiotoxicity Induced by Doxorubicin and Doxorubicin with Cyclophosphamide in Mice
    Snežana Bjelogrlić, Jelena Radić, Viktor Jović, Sinisa S. Radulovic · 2005 · Basic & Clinical Pharmacology & Toxicology
  88. Inhibition by adriamycin of the mitochondrial biosynthesis of coenzyme Q10 and implication for the cardiotoxicity of adriamycin in cancer patients
    Karl Folkers, Margaret Liu, Tatsuo Watanabe, Thomas Hugh Porter · 1977 · Biochemical and Biophysical Research Communications
  89. Voluntary wheel running in rats receiving doxorubicin: effects on running activity and cardiac myosin heavy chain.
    David Scott Hydock, Karen Y. Wonders, Carole M. Schneider, Reid Hayward · 2009 · PubMed
  90. Rehabilitative exercise in a rat model of doxorubicin cardiotoxicity
    David Scott Hydock, Chia‐Ying Lien, Brock T. Jensen, Traci L. Parry, Carole M. Schneider, Reid Hayward · 2012 · Experimental Biology and Medicine
  91. Exercise Mitigates Cardiac Doxorubicin Accumulation and Preserves Function in the Rat
    Brock T. Jensen, Chia‐Ying Lien, David Scott Hydock, Carole M. Schneider, Reid Hayward · 2013 · Journal of Cardiovascular Pharmacology
  92. Transcriptome Profiling of Peripheral Blood Cells Identifies Potential Biomarkers for Doxorubicin Cardiotoxicity in a Rat Model
    Valentina K. Todorova, Marjorie L. Beggs, Robert R. Delongchamp, Ishwori B. Dhakal, Issam Makhoul, Jeanne Y. Wei, Vicki Suzanne Klimberg · 2012 · PLoS ONE
  93. Phase I study of ICRF-187 using a daily for 3 days schedule.
    Von Hoff, Dianne M. Howser, Lewis Bj, John S. Holcenberg, Raymond B. Weiss, Young Rc · 1981 · PubMed
  94. Dendritic cells in the hearts of spontaneously hypertensive rats treated with doxorubicin with or without ICRF-187.
    J Zhang, Erik Herman, Victor J. Ferrans · 1993 · PubMed
  95. Cardioprotective Effects of a Novel Iron Chelator, Pyridoxal 2-Chlorobenzoyl Hydrazone, in the Rabbit Model of Daunorubicin-Induced Cardiotoxicity
    Martin Štěrba, Olga Popelová, Tomáš Šimůnek, Y Mazurová, Anna Potáčová, Michaela Adamcová, Helena Mertlíková‐Kaiserová, Přemysl Poňka, Vladimír Geršl · 2006 · Journal of Pharmacology and Experimental Therapeutics
  96. Anti-inflammatory agents and monoHER protect against DOX-induced cardiotoxicity and accumulation of CML in mice
    Anna M E Bruynzeel, M A Abou El Hassan, Caspar Schalkwijk, Johannes Hans Berkhof, Aalt Bast, Hans W.M. Niessen, Wim J.F. van der Vijgh · 2007 · British Journal of Cancer
  97. Identification of the site of adriamycin-activation in the heart cell
    Hans Nohl · 1988 · Biochemical Pharmacology
  98. Alteration of Matrix Metalloproteinases in Selective Left Ventricular Adriamycin-Induced Cardiomyopathy in the Pig
    Andreas Goetzenich, Nima Hatam, Alma Zernecke, Christian Weber, Tanja Czarnotta, Rüdiger Autschbach, Stefan Christiansen · 2009 · The Journal of Heart and Lung Transplantation
  99. Rescue by coenzyme Q10 from electrocardiographic abnormalities caused by the toxicity of adriamycin in the rat.
    Karl Folkers, J Y Choe, Alan B. Combs · 1978 · Proceedings of the National Academy of Sciences
  100. Lack of Effect of Coenzyme Q10 on Doxorubicin Cytotoxicity in Breast Cancer Cell Cultures
    Heather Greenlee, Jacquelyn M. Shaw, Ying-Ka Ingar Lau, Ali Naini, Matthew Maurer · 2012 · Integrative Cancer Therapies
  101. Doxorubicin cardiotoxicity in children: Reduced incidence of cardiac dysfunction associated with continuous-infusion schedules
    Su Gülsün Berrak, Michael S. Ewer, Norman Jaffe, Peggy Pearson, Hubert L. Ried, Hallie A. Zietz, Robert S. Benjamin · 2001 · Oncology Reports
  102. Nitric Oxide Synthase Expressions in ADR-induced Cardiomyopathy in Rats
    Baogang Liu, Hongli Li, Hongyan Qu, Baogui Sun · 2006 · BMB Reports
  103. Neurotrophins Induce Neuregulin Release through Protein Kinase Cδ Activation
    Raymond M. Esper, Jeffrey A. Loeb · 2009 · Journal of Biological Chemistry
  104. Longitudinal Left Ventricular Strain in Hypertrophic Cardiomyopathy: Correlation with Nonsustained Ventricular Tachycardia
    Emanuel Correia, Bruno Rodrigues, Luís Ferreira dos Santos, Davide Moreira, Pedro Gama, Costa Cabral, Oliveira Santos · 2011 · Echocardiography
  105. Can Anthracycline Therapy for Pediatric Malignancies Be Less Cardiotoxic?
    Joy Marie Fulbright, Winston W. Huh, Pete M. Anderson, Joya Chandra · 2010 · Current Oncology Reports
  106. Regional cardiac wall motion abnormalities during and shortly after anthracyclines therapy
    Livia Kapusta, Jacqueline J. Loonen, JOHAN M. THIJSSEN, Ruurd deGraaf, O. Daniëls · 2003 · Medical and Pediatric Oncology
  107. Dobutamine Stress Echocardiography Identifies Anthracycline Cardiotoxicity
    Yves Cottin · 2000 · European Journal of Echocardiography
  108. Toxicity profile of dexrazoxane (zinecardR, icrf-187, adr-529, nsc-169780), a modulator of doxorubicin cardiotoxicity
    Charles F. Curran · 1991 · Cancer Treatment Reviews
  109. Endothelin in chronic heart failure: current position and future prospects
    M LOVE, J MCMURRAY · 1996 · Cardiovascular Research
  110. The NADH oxidase system (external) of muscle mitochondria and its role in the oxidation of cytoplasmic NADH
    Ulla F. Rasmussen, H N Rasmussen · 1985 · Biochemical Journal
  111. Amelioration of doxorubicin-induced cardiotoxicity by deferiprone in rats
    Elsayed M. Ammar, Shehta A. Said, Ghada Mohamed Suddek, Sally L. El-Damarawy · 2011 · Canadian Journal of Physiology and Pharmacology
  112. Normal values and reproducibility of left ventricular filling parameters by radionuclide angiography
    H. J. Muntinga, Frederik van den Berg, Hans R. Knol, Menco G. Niemeyer, Paul K. Blanksma, Henk Louwes, Ernst Evert van der Wall · 1997 · International journal of cardiac imaging
  113. Neuregulin-1/erbB activities with focus on the susceptibility of the heart to anthracyclines
    Cecilia Vasti · 2014 · World Journal of Cardiology
  114. METABOLISM OF THE ONE-RING OPEN METABOLITES OF THE CARDIOPROTECTIVE DRUG DEXRAZOXANE TO ITS ACTIVE METAL-CHELATING FORM IN THE RAT
    Patricia E. Schroeder, Brian B. Hasinoff · 2005 · Drug Metabolism and Disposition
  115. The doxorubicin-cardioprotective drug dexrazoxane undergoes metabolism in the rat to its metal ion-chelating form ADR-925
    Patricia E. Schroeder, Brian B. Hasinoff · 2002 · Cancer Chemotherapy and Pharmacology
  116. Synergistic activity of doxorubicin and the bisdioxopiperazine (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF 187) against the murine sarcoma S180 cell line.
    Scott Wadler, M D Green, Franco M. Muggia · 1986 · PubMed
  117. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer
    Elske Sieswerda, Elvira C van Dalen, Aleida Postma, Daniel KL Cheuk, Huib N. Caron, Leontien C.M. Kremer · 2011 · Cochrane Database of Systematic Reviews
  118. Vascular Injury in Cancer Survivors
    Daniel A. Mulrooney, Anne Hudson Blaes, Daniel A. Duprez · 2012 · Journal of Cardiovascular Translational Research
  119. Protective effect of calceolarioside on adriamycin-induced cardiomyocyte toxicity
    Do‐Sung Kim, Hyung‐Ryong Kim, Eun‐Rhan Woo, Dae‐Young Kwon, Myung‐Sunny Kim, Soo‐Wan Chae, Han–Jung Chae · 2006 · European Journal of Pharmacology
  120. DAUNORUBICIN IN ACUTE MYELOCYTIC LEUKqMIA
    James S. Malpas · 1969 · The Lancet
  121. Effects of Autologous Stem Cells on Immunohistochemical Patterns and Gene Expression of Metalloproteinases and Their Tissue Inhibitors in Doxorubicin Cardiomyopathy in a Rabbit Model
    Heike Aupperle, Jens Garbade, A. Schubert, Markus Johannes Barten, Stefan Dhein, H.-A. Schoon, F. Mohr · 2007 · Veterinary Pathology
  122. Induction of manganese superoxide dismutase (MnSOD) mediates cardioprotective effect of tamoxifen (TAM)
    Chotiros Daosukho, Wanida Ittarat, S.J Lin, Douglas B. Sawyer, Kelley K. Kiningham, Yu‐Chin Lien, Daret K. St. Clair · 2005 · Journal of Molecular and Cellular Cardiology
  123. Superoxide Anions Contribute to Impaired Regulation of Blood Pressure by Nitric Oxide During the Development of Cardiomyopathy
    Jose A. Gutierrez, Shawn G. Clark, Ararat D. Giulumian, Leslie C. Fuchs · 1997 · Journal of Pharmacology and Experimental Therapeutics
  124. dl-N,N'-dicarboxamidomethyl-N,N'-dicarboxymethyl-1,2-diaminopropane (ICRF-198) and d-1,2-bis(3,5-dioxopiperazine-1-yl)propane (ICRF-187) inhibition of Fe3+ reduction, lipid peroxidation, and CaATPase inactivation in heart microsomes exposed to adriamycin.
    Glenn F. Vile, Christine C. Winterbourn · 1990 · PubMed
  125. Doxorubicin-Induced Vascular Dysfunction and Its Attenuation by Exercise Preconditioning
    Noah M. Gibson, Stephanie E. Greufe, David Scott Hydock, Reid Hayward · 2013 · Journal of Cardiovascular Pharmacology
  126. Inhibition and inactivation of NADH-cytochrome c reductase activity of bovine heart submitochondrial particles by the iron(III)-adriamycin complex
    Brian B. Hasinoff · 1990 · Biochemical Journal
  127. Strategies to Prevent Anthracycline-Related Congestive Heart Failure in Survivors of Childhood Cancer
    Saro H. Armenian, Sarah K. Gelehrter, Eric Jessen Chow · 2012 · Cardiology Research and Practice
  128. Dexrazoxane in combination with anthracyclines lead to a synergistic cytotoxic response in acute myelogenous leukemia cell lines
    Michael L. Pearlman, David B. Jendiroba, Lance C. Pagliaro, Afsaneh Keyhani, Baoshun Liu, Emil J. Freireich · 2003 · Leukemia Research
  129. Increased Plasma Endothelin‐1 and Cardiac Nitric Oxide during Doxorubicin‐Induced Cardiomyopathy
    Mohamed M. Sayed‐Ahmed, Mahmoud M. Khattab, Mohamed Zakaria Gad · 2001 · Pharmacology & Toxicology
  130. Normalised radionuclide measures of left ventricular diastolic function
    KennethJ. Lee, ANDREW E. SOUTHEE, George J. Bautovich, Ben Freedman, Andrew F. McLaughlin, Monica Anne Rossleigh, Brian F. Hutton, JG Morris · 1989 · European Journal of Nuclear Medicine and Molecular Imaging
  131. [Cardiac complications observed during treatment with rubidomycin].
    C Macrez, H Marneffe-Lebréquier, J Ripault, Jean‐Pierre Clauvel, C Jacquillat, Marise Weil · 1967 · PubMed
  132. Adriamycin-Fe3+-Induced Inactivation of Rat Heart Mitochondrial Creatine Kinase: Sensitivity to Lipid Peroxidation.
    Toshiaki Miura, Sanae Muraoka, Taketo Ogiso · 1994 · Biological and Pharmaceutical Bulletin
  133. Pediatric cardiomyopathy as a chronic disease: A perspective on comprehensive care programs
    Natalya Bublik, Jorge A. Alvarez, Steven E. Lipshultz · 2008 · Progress in Pediatric Cardiology
  134. The tell-tale heart: molecular and cellular responses to childhood anthracycline exposure
    Merry L. Lindsey, Richard A. Lange, Helen M. Parsons, Thomas C. Andrews, Gregory John Aune · 2014 · American Journal of Physiology-Heart and Circulatory Physiology
  135. Neuregulin-1 Protects Against Doxorubicin-Induced Apoptosis in Cardiomyocytes Through an Akt-Dependent Pathway
    T. AN, Y. ZHANG, Y. HUANG, R. ZHANG, S. YIN, X. GUO, Yirong Wang, Chang Hong Zou, B. WEI, R. LV et al. · 2013 · Physiological Research
  136. Plasma coenzyme Q10 in children and adolescents undergoing doxorubicin therapy
    Simon D. Eaton, Roderick Skinner, Juliet Hale, Morteza Pourfarzam, A. A. Roberts, Lisa Price, K. Bartlett · 2000 · Clinica Chimica Acta
  137. Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignancies.
    Merry L. Tetef, Timothy Walter Synold, Warren Allen Chow, Lucille Leong, Kim Allyson Margolin, Robert J. Morgan, James W. Raschko, Stephen Shibata, George Somlo, Yun Yen et al. · 2001 · PubMed
  138. Human neuronal nitric oxide synthase can catalyze one-electron reduction of adriamycin: role of flavin domain
    Jie Fu, Keita Yamamoto, Zhiwen Guan, Shigenobu Kimura, Takashi Iyanagi · 2004 · Archives of Biochemistry and Biophysics
  139. Pilot study of vascular health in survivors of Hodgkin lymphoma
    Daniel A. Mulrooney, Kirsten K. Ness, Anna N. Solovey, Robert P. Hebbel, James D. Neaton, Bruce A. Peterson, Chung K.K. Lee, Aaron S. Kelly, Joseph Philip Neglia · 2012 · Pediatric Blood & Cancer
  140. Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer
    Elvira C van Dalen, Martine F. Raphaël, Huib N. Caron, Leontien C.M. Kremer · 2009 · Cochrane Database of Systematic Reviews
  141. FLAG-liposomal Doxorubicin (Myocet) Regimen for Refractory or Relapsed Acute Leukemia Pediatric Patients
    Paola Quarello, Massimo Berger, Elisa Rivetti, Chiara Galletto, Riccardo Masetti, Rosaria Manicone, Elena Barisone, Andrea Pession, Franca Fagioli · 2012 · Journal of Pediatric Hematology/Oncology
  142. Subacute Anthracycline Cardiotoxicity
    Christopher L. Hengel, Prudence Anne Russell, Paul A. Gould, David M. Kaye · 2005 · Heart Lung and Circulation
  143. Multi-modality imaging of diastolic function
    Michael Salerno · 2010 · Journal of Nuclear Cardiology
  144. Long-term effects of 7-monohydroxyethylrutoside (monoHER) on DOX-induced cardiotoxicity in mice
    Anna M E Bruynzeel, Suzanne Vormer-Bonne, Aalt Bast, Hans W.M. Niessen, Wim J.F. van der Vijgh · 2006 · Cancer Chemotherapy and Pharmacology
  145. Daunomycin Treatment in Chronic Lymphoproliferative Disorders
    Gianni Bonadonna, Silvio Monfardini, Antonio Guindani · 1968 · Tumori Journal
  146. In vivo studies on adriamycin-induced lipid peroxidation and effects of ferrous ions.
    Hermann Kappus, Hassan Muliawan, Max Ernst Scheulen · 1980 · PubMed
  147. Pulmonary Fibrosis after Pegylated Liposomal Doxorubicin in Elderly Patient with Cutaneous Angiosarcoma
    Marco Mazzotta, Raffaele Giusti, Daniela Iacono, Salvatore Di Lauro, Paolo Marchetti · 2016 · Case Reports in Oncological Medicine
  148. Ventricular Systolic Reserve in Asymptomatic Children Previously Treated With Low Doses of Anthracyclines
    Fábio Villaça Guimarães Filho, Doralice Marvulle Tan, Joao Braga, Alexandre Rodrigues, Paulo Henrique Waib, Beatriz Bojikian Matsubara · 2007 · The American Journal of Cardiology
  149. Pilot study of vascular health in survivors of osteosarcoma
    Daniel A. Mulrooney, Kirsten K. Ness, Sujuan Huang, Anna N. Solovey, Robert P. Hebbel, James D. Neaton, Denis R. Clohisy, Aaron S. Kelly, Joseph Philip Neglia · 2013 · Pediatric Blood & Cancer
  150. Coenzyme Q10 and adriamycin toxicity in mice.
    James Shaeffer, A. M. El-Mahdi, Richard K. Nichols · 1980 · PubMed
  151. Cardiac Toxicity Screening by Echocardiography in Healthy Volunteers: A Study of the Effects of Diurnal Variation and Use of a Core Laboratory on the Reproducibility of Left Ventricular Function Measurement
    Sacha Bull, Michael L. Main, Gary R. Stevens, Jonathan H. Goldman, Simon A. Constable, Harald H. Becher · 2011 · Echocardiography
  152. A precise pharmacodynamic study showing the advantage of a marked reduction in cardiotoxicity in continuous infusion of doxorubicin
    Taizo Ishisaka, Shinji Kishi, Kiyotaka Okura, Motosaburo Horikoshi, Taro Yamashita, Yasuhiko Mitsuke, Hiromasa Shimizu, Takanori Ueda · 2006 · Leukemia & lymphoma/Leukemia and lymphoma
  153. Interaction of anthracycline antibiotics with human neutrophils: superoxide production, free radical formation and intracellular penetration
    Maria Luisa Schinetti, Daniele Rossini, A. Bertelli · 1987 · Journal of Cancer Research and Clinical Oncology
  154. The late effects of cancer therapy in childhood
    P H Morris Jones · 1991 · British Journal of Cancer
  155. Mitral Regurgitation due to Papillary Muscle Dyssynchrony during Trastuzumab Treatment
    Can Yücel Karabay, Gönenç Kocabay, Arzu Kalaycı, Regaip Zehir, İbrahi̇m Hali̇l Tanboğa · 2010 · Cardiology
  156. Targeted Ultrasound Imaging of Apoptosis with Annexin A5 Microbubbles in Acute Doxorubicin-Induced Cardiotoxicity
    Pil‐Ki Min, Soyeon Lim, Soo-Jung Kang, Sung‐Yu Hong, Ki‐Chul Hwang, Kwang‐Hoe Chung, Chi Young Shim, Se‐Joong Rim, Namsik Chung · 2010 · Journal of Cardiovascular Ultrasound
  157. Influence of liver-X-receptor on tissue cholesterol, coenzyme Q and dolichol content
    Magnus Bentinger, Michael Tekle, Gustav Dallner, Kerstin Brismar, Jan-Ακε Gustafsson, Knut Rune Steffensen, Sergiu‐Bogdan Catrina · 2012 · Molecular Membrane Biology
  158. Pulmonary Fibrosis After Pegylated Liposomal Doxorubicin in a Patient With Uterine Papillary Serous Carcinoma
    Nicole Suzanne Nevadunsky, Chinyere Mbagwu, Nina Mizrahi, Elizabeth M. Burton, Gary L. Goldberg · 2013 · Journal of Clinical Oncology
  159. Effect of Doxorubicin on Fibroblast Migration and Proliferation
    L. Pérez, Isabel Pinilla, F Gonzalvo, S. Pérez Oliván, Francisco Manuel Honrubia · 2003 · Annals of Ophthalmology
  160. Restrictive Cardiomyopathy Associated With Left Ventricle and Left Atria Endocardial Calcifications Following Chemotherapy
    Soulef Guendouz, Otilia Buicuic, Matthias E.W. Kirsch, Nicole Benaiem, Jean-Ernest Poulard, Jean‐François Deux, Luc Hittinger, Marcel Peltier, Thibaud Damy · 2011 · Journal of the American College of Cardiology
  161. A Phase I/II Study of 6-Hour and 24-Hour Intravenous Infusions of Doxorubicin
    James L. Speyer, M. D. Green, Joseph C. Bottino, J Wernz, Ronald H. Blum, Franco M. Muggia · 1982 · Springer eBooks
  162. Actualités hématologiques
    1970 · Revue Française de Transfusion